The use of a combination of daunorubicin and cytosine arabinoside in the treatment of acute myeloid leukaemia in a district general hospital is described. The results in a series of 30 cases are considered.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.